Sees growth increasing over time. Opportunities to outperform, including Medicare Advantage margin improvement, are projected to add 3%-4% to adjusted EPS in 2025, CVS said in Investor Day presentation slides.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CVS:
- CVS Health (NYSE:CVS) Rises on Bullish FY24 Outlook and Dividend Hike
- CVS Health highlights path to accelerating long-term growth through building a world of health around every consumer
- CVS Health to hold investor day
- 3 Best Stocks to Buy Now, 11/22/2023, According to Top Analysts
- Foot Locker, Teamsters drop drug-benefit managers over costs, WSJ says
